Laboratory studies identify a potential way to treat human cancers with ARID1A mutations
A new study shows that tumor cells depleted of ARID1A—a protein that acts as a cancer suppressor—become highly sensitive to anticancer poly ADP ribose polymerase (PARP) inhibitor drugs after radiation treatment. The research, ...
Aug 19, 2019
0
4